Get started Log in

NVRO — Nevro Share News

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapTurnaround

Market Cap
$221.21m
Enterprise Value
$154.31m
Revenue
$408.52m

Nevro Corp reports results for the quarter ended in September - Earnings Summary
02/11/2022 22:05
Brief: Nevro Reports Third Quarter 2022 Financial Results
02/11/2022 21:50
Nevro Corp expected to post a loss of 10 cents a share - Earnings Preview
01/11/2022 02:03
U.S. RESEARCH ROUNDUP-Adobe, BlackRock, Domino's Pizza
17/10/2022 07:52
Brief: Nevro Announces FDA Approval Of HFX IQ Spinal Cord Stimulation System To Personalize Treatment Of Chronic Pain
12/10/2022 23:32
Brief: Nevro Comments On Unitedhealthcare Medical Coverage Policy Update
10/10/2022 12:42
Brief: Nevro Announces FDA Approval Of Costa Rica Manufacturing Operations
04/10/2022 21:08
Brief: Nevro Reports Second Quarter 2022 Financial Results
03/08/2022 22:39
Brief: Nevro And Boston Scientific Announce The Settlement Of Their Ongoing Intellectual Property Litigations
01/08/2022 12:43
Brief: Nevro Corp - Latest Clinical Data on Nevro HFX Spinal Cord Stimulation Therapy Shows Substantial Improvement In Patients With Painful Diabetic Neuropathy
05/07/2022 12:40
NYSE ORDER IMBALANCE 79222.0 SHARES ON BUY SIDE
24/06/2022 20:51
Brief: Nevro Presents Clinical Data On HFX 10 kHz Therapy
07/06/2022 21:25
Brief: Nevro Reports First Quarter 2022 Financial Results
04/05/2022 23:18
Nevro Corp expected to post a loss of $1.10 a share - Earnings Preview
03/05/2022 02:58
NYSE ORDER IMBALANCE 94550.0 SHARES ON BUY SIDE
08/03/2022 20:50
Brief: Nevro Announces Positive Medicare Coverage Update From Noridian For Treatment Of Painful Diabetic Neuropathy
07/03/2022 21:13
NYSE ORDER IMBALANCE 135879.0 SHARES ON SELL SIDE
02/03/2022 20:50
NYSE ORDER IMBALANCE 60383.0 SHARES ON BUY SIDE
28/02/2022 20:50
Brief: Nevro Reports Q4 And Full-Year 2021 Results
23/02/2022 22:43
Nevro Corp reports results for the quarter ended in December - Earnings Summary
23/02/2022 22:02